Why vitamin D3 and K2 are studied as a pair
Vitamin D3 (cholecalciferol) raises the body's ability to absorb dietary calcium from the gut, which is why it sits at the center of bone-health discussions. Vitamin K2 (menaquinone) activates two calcium-handling proteins, osteocalcin and matrix Gla protein, that influence where that calcium is deposited. The proposed rationale for pairing them is that D3 increases calcium availability while K2-dependent proteins help direct calcium toward bone rather than soft tissue.
This is a mechanistic hypothesis supported by biochemistry, not a settled clinical guarantee. Trials on combined supplementation show mixed results, and outcomes depend on baseline status, dose, and the population studied.
What the diagram is illustrating versus what is proven
The chart depicts the complementary roles: absorption on the D3 side, distribution on the K2 side. The idea that the two outperform either alone is plausible mechanistically but the human evidence for hard endpoints like fracture reduction from combined dosing remains preliminary.
This is general educational information, not medical advice. Fat-soluble vitamins can accumulate, and vitamin K interacts with anticoagulant medication such as warfarin. Anyone considering supplementation, especially at higher doses or alongside prescriptions, should consult a qualified clinician first.